These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6950403)

  • 1. Phenylketonuric Tetrahymena: phenylalanine hydroxylase mutants and other tyrosine auxotrophs.
    Sanford YM; Orias E
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7614-8. PubMed ID: 6950403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pteridines and mono-amines: relevance to neurological damage.
    Smith I; Howells DW; Hyland K
    Postgrad Med J; 1986 Feb; 62(724):113-23. PubMed ID: 3540926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
    Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
    N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of the mammalian phenylalanine hydroxylase system: I. Isolation of phenylalanine hydroxylase-deficient tyrosine auxotrophs from rat hepatoma cells.
    Choo KH; Cotton RG
    Somatic Cell Genet; 1977 Sep; 3(5):457-70. PubMed ID: 199952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and biochemistry of the phenylketonuria-present state.
    Bartholomé K
    Hum Genet; 1979 Oct; 51(3):241-5. PubMed ID: 511154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].
    Rey F; Harpey JP; Leeming RJ; Blair JA; Aicardi J; Rey J
    Arch Fr Pediatr; 1977; 34(7 Suppl):CIX-CXX. PubMed ID: 931522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of pteridine biosynthesis and aromatic amino acid hydroxylation in Drosophila melanogaster.
    Bel Y; Ferré J
    Biochem Genet; 1989 Feb; 27(1-2):59-76. PubMed ID: 2496683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.
    Bartholomé K; Byrd DJ; Kaufman S; Milstien S
    Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylketonuria and other phenylalanine hydroxylation mutants in man.
    Scriver CR; Clow CL
    Annu Rev Genet; 1980; 14():179-202. PubMed ID: 7011173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenylketonuria].
    Feillet F
    Presse Med; 2006 Mar; 35(3 Pt 2):502-8. PubMed ID: 16550150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
    Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
    Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis of phenylketonuria.
    Erlandsen H; Stevens RC
    Mol Genet Metab; 1999 Oct; 68(2):103-25. PubMed ID: 10527663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylalanine hydroxylation cofactor in phenylketonuria.
    KAUFMAN S
    Science; 1958 Dec; 128(3337):1506-8. PubMed ID: 13615302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced 6,6,8-trimethylpterins. Preparation, properties and enzymic reactivities with dihydropteridine reductase, phenylalanine hydroxylase and tyrosine hydroxylase.
    Randles D; Armarego WL
    Eur J Biochem; 1985 Jan; 146(2):467-74. PubMed ID: 2857123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
    Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of L-tryptophan 5-hydroxylation activity by structure-based modification of L-phenylalanine 4-hydroxylase from Chromobacterium violaceum.
    Kino K; Hara R; Nozawa A
    J Biosci Bioeng; 2009 Sep; 108(3):184-9. PubMed ID: 19664549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrobiopterin loading test in hyperphenylalaninemia.
    Ponzone A; Guardamagna O; Ferraris S; Ferrero GB; Dianzani I; Cotton RG
    Pediatr Res; 1991 Nov; 30(5):435-8. PubMed ID: 1754298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of phenylalanine hydroxylase (EC 1.14.3.1) in liver and kidney of vertebrates.
    Hsieh MC; Berry HK
    J Exp Zool; 1979 May; 208(2):161-7. PubMed ID: 469481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperphenylalaninemia in 1981. A diagnostic approach (author's transl)].
    Dhondt JL; Farriaux JP
    Arch Fr Pediatr; 1981 Oct; 38(8):573-8. PubMed ID: 7316669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.